3D Bioprinting Market Revenue to Increase at 15.4% CAGR, to reach USD 5.1 Billion By 2030, Says MRFR

It has been estimated that the market for 3D bioprinting is about to grow; the projected numbers from 2021 were $1.6 billion. The forecasted CAGR is almost 15.4% from 2022 to 2030.

3D bioprinting is first and foremost a healthcare-based technology that is evolving rapidly to become a multi-billion-dollar industry. In simple terms, a biological 3D printer creates simple human tissue structures under controlled laboratory conditions. It has been estimated that in the near future, this state-of-the-art technology will be used to create whole human organs for transplantation. Currently, this process is at a start-up stage when partially controlled cell models are done via 3D. This technology is also used to research and develop modern drugs and organic human implants. Thus, the 3D bioprinting market has witnessed a boom in the new age of medical procedures.

Get a Sample Copy of "3D Bioprinting Market" @ https://www.marketresearchfuture.com/sample_request/869

Key Players

Organovo Holdings, Inc. (US)

ROKIT Healthcare (South Korea)

Cyfuse Biomedical K.K. (Japan)

CELLINK (Sweden)

EnvisionTEC GmbH (Germany)

Allevi Inc. (US)

Aspect Biosystems Ltd. (Canada)

Segmental Analysis

The 3D Bioprinting market is segmented into material, application and technology. The 3D printing market is segmented into biomaterial, hydrogels, and cells on the material front. It is used in the pharmaceutical industry, organ and tissue regeneration, and 3D cell culture through the application. When it comes to technology use, this advanced medical technology is used inkjet, laser, syringe and pneumatic extrusion based.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/3d-bioprinting-market-869

Regional Analysis

The 3D bioprinting market can be geographically divided into Europe, the Middle East & Africa (MEA) along with Asia Pacific (APAC), as well as the Americas.

Since 2017, the American market has continued to be in the lead as the demand for 3D products has been on a constant upward trajectory in the region. The extensive pool of additive manufacturers and the sound financial status of the patients add to the lucrativeness of the biofabrication market in the region. The recent COVID-19 pandemic has prompted accelerated development of vaccine and drug testing, with scientists increasingly using 3D bio-printing technology to safety-test patients post preclinical trials. Numerous biotherapeutic firms in the region are making use of the 3D bioprinting technology to conduct the novel coronavirus research. To illustrate, in August 2020, Viscient Biosciences deployed the 3D bioprinting technology to develop lung tissue that backs viral infectivity research, while also exploring efficient therapy against the SARS-CoV-2 infection. In a nutshell, the 3D bioprinting market in the Americas has been given a boost with the growing need to find a COVID-19 breakthrough.

APAC is set to display the fastest growth rate over the next few years, thanks to the fast advancing healthcare industry in China and India. The increasing spending on research and development and the alarming rate at which mortality has surged since the COVID-19 outbreak in the region also favor the market. The lack of organ donors further ensures growth in the 3D bioprinting market in APAC, while the trend of rising use of magnetic levitation technology in the healthcare sector for vascular muscle printing, human cell regeneration and toxicity screening. In short, the bioprinting market potential in the region is touted to remain strong throughout the evaluation period.

Browse Related Reports

https://www.marketresearchfuture.com/reports/ai-drug-discovery-market-9393

https://www.marketresearchfuture.com/reports/telemedicine-market-2216

https://www.marketresearchfuture.com/reports/gene-therapy-market-8399

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

This release was published on openPR.